Description

[(2R,3R,4S,5R,6R)-5-hydroxy-6-[2-(3-hydroxy-4-methoxy-phenyl)ethoxy]-2-(hydroxymethyl)-4-[(2S,3R,4R,5S,6S)-3,4,5-trihydroxy-6-methyl-oxan-2-yl]oxy-oxan-3-yl] (E)-3-(3-hydroxy-4-methoxy-phenyl)prop-2-enoate is a high-purity, complex glycosidic ester compound of significant interest in advanced research and development. This molecule is valued for its specific stereochemistry and potential bioactive properties derived from its phenolic and sugar moieties. It serves as a critical intermediate or reference standard for pharmaceutical discovery, nutraceutical formulation, and biochemical studies targeting oxidative stress and metabolic pathways.

Application

• Pharmaceutical Intermediate: Used in the research and synthesis of novel drug candidates, particularly those targeting inflammation, diabetes, and neurodegenerative diseases.
• Reference Standard: Serves as a high-purity analytical standard for quality control and method development in pharmaceutical and nutraceutical laboratories.
• Nutraceutical & Cosmetic Research: Investigated for its potential antioxidant and anti-aging properties in functional food, dietary supplement, and advanced skincare formulations.
• Biochemical Research: Employed as a tool compound in enzymatic studies, receptor binding assays, and metabolic pathway analysis.
• Process Chemistry: Acts as a key building block in the multi-step synthesis of complex natural product analogs and specialty fine chemicals.

Basic Information

Product Name	[(2R,3R,4S,5R,6R)-5-hydroxy-6-[2-(3-hydroxy-4-methoxy-phenyl)ethoxy]-2-(hydroxymethyl)-4-[(2S,3R,4R,5S,6S)-3,4,5-trihydroxy-6-methyl-oxan-2-yl]oxy-oxan-3-yl] (E)-3-(3-hydroxy-4-methoxy-phenyl)prop-2-enoate
CAS No.	80377-39-5
Molecular Formula	C31H38O14
Molecular Weight	634.63 g/mol
Synonyms	Acteoside; Verbascoside; Kusaginin; Cistanoside C; Torenoside B; 2-(3,4-Dihydroxyphenyl)ethyl 3-O-(6-deoxy-α-L-mannopyranosyl)-4-O-[(2E)-3-(3,4-dihydroxyphenyl)-2-propenoyl]-β-D-glucopyranoside; β-(3,4-Dihydroxyphenyl)ethyl O-α-L-rhamnopyranosyl-(1→3)-4-O-caffeoyl-β-D-glucopyranoside
EINECS	Contact for details

Quality Control

Our high-purity grade of this compound is manufactured under strict quality management systems. Each batch is subjected to comprehensive analytical testing including HPLC for purity, NMR for structural confirmation, and MS for identity verification to ensure it meets stringent specifications for research use. Certificates of Analysis (COA) detailing all test results are provided and we can support compliance with cGMP, ICH Q7, and relevant pharmacopeial guidelines upon request.

Storage

Preserve in a tightly closed container, protected from light. Store at -20°C or below under an inert atmosphere (e.g., argon or nitrogen) for long-term stability. This compound is hygroscopic (moisture-sensitive) and easily oxidized; allow the sealed container to equilibrate to room temperature before opening to minimize condensation and exposure to air.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (HPLC)	Conforms to reference standard
Identification (NMR)	Conforms to structure
Purity (HPLC)	≥ 98.0%
Water Content (KF)	≤ 2.0%
Residue on Ignition	≤ 0.1%
Heavy Metals	≤ 10 ppm
Residual Solvents (GC)	Complies with ICH Q3C

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.